General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1. At a Glance
ACC sold 73.7 Mt of cement in FY26, a 16% jump year-on-year and management’s “highest-ever” annual volume. Revenue hit ₹25,962 Cr, up 18% from ₹21,920 Cr in FY25.
But the expansion was uneven. Acquired assets—Penna, Sanghi, Orient—underperformed: lower-than-expected utilization, surprise maintenance costs, and operational hiccups dragged margins tighter than expected.
Net profit fell 11% to ₹2,137 Cr from ₹2,402 Cr in FY25, despite the top-line muscle. EPS skid 11% to ₹113.80 from ₹127.92. The company explicitly flagged costs “peaked” at ₹4,500/tonne in Q4 and promised a ₹250/tonne reduction in FY27—a credibility test after missing prior guidance.
Balance sheet remains fortress-like: ₹429 Cr net debt against ₹25,512 Cr market cap, CRISIL AAA rating, near-zero leverage. But integration headaches, not balance sheet strength, are the headline.
2. Introduction
ACC, India’s oldest cement maker (founded 1936), is now 50% owned by Ambuja Cements, which is controlled by Adani. The group—Ambuja and ACC combined—was the second-largest cement player in India as of Sep 2025 with 107 MTPA capacity.
FY26 was a capex and M&A year. The company acquired 55% of Asian Concretes & Cements (2.8 MTPA) in January 2024 for ₹775 Cr. It also integrated Penna Cement (acquired in FY25) and Sanghi Industries mid-year, bulking up capacity from 38.55 MTPA (end-FY24) to over 40 MTPA standalone by FY26.
Management signaled a shift in December 2025: approval to merge ACC into Ambuja, subject to regulatory clearance. This simplifies the holding structure but adds near-term integration distraction.
The quarter ending March 2026 (Q4 FY26) saw sales of ₹7,146 Cr, a 16.9% lift YoY, but net profit collapsed 62.9% to ₹238 Cr. That quarter-on-quarter trough frames the tension: volumes up, but costs and complexity up faster.
3. Business Model: WTF Do They Even Do?
Cement is ACC’s domain: 94% of FY24 revenue and still dominant in FY26.
The company sells two tiers. Gold range (premium): ACC Gold Water Shield, ACC F2R Superfast—marketed to high-end construction. Silver range (mass-market): ACC Suraksha Power, ACC HPC Long Life, ACC Suraksha Power+—competing on price and availability.
FY26 saw premiumization push: trade volume (retail focused) climbed to ~74% of sales, and premium cement hit ~36% of trade sales in Q4. Average realization for cement rose to ₹5,092/tonne (FY24) from ₹4,973/tonne (FY19), a 2% CAGR—not a blowout, but deliberate up-market positioning.
Ready-mix concrete (RMC) is the other leg: 6% of FY24 revenue, down from 9% in FY19. The company runs 86+ RMC plants and sells value-added brands (ACC ECOMAxX, ACC AEROMAxX). This segment grew on realization (+14% per cubic meter from FY19 to FY24) but contracted on volume (down 24%).
Distribution: 13,000+ channel partners and 39,600 retailers (per About section). Retail accounts for 72% of sales, wholesale 28%. The MSA (Master Supply Agreement) with Ambuja is a structural deal: ACC sold 6.6 Mt of clinker and cement to Ambuja in FY24, boosting volume and “profitability,” management says.
The business model is vanilla cement: extract, grind, sell, compete on cost and proximity to end-use. Nothing novel, everything dependent on construction demand, input costs (fuel, raw materials), and logistics.
4. Financials Overview
Figures are consolidated, in ₹ crore.
| Metric | Latest (FY26) | Prior (FY25) | Change |
|---|---|---|---|
| Revenue | 25,962 | 21,920 | +18.4% |
| EBITDA | 2,958 | 3,061 | -3.3% |
| PAT | 2,137 | 2,402 | -11.0% |
| EPS | 113.80 | 127.92 | -11.0% |
FY26 revenue climbed ₹4,042 Cr YoY, a clean 18.4% increase. Sales growth was broad: Cement volumes up 16%, RMC realizations contributing, and acquired assets in the mix for a full year (Penna) or partial year (Sanghi).
Yet EBITDA declined 3.3% to ₹2,958 Cr despite higher sales. This inversion signals margin compression—cost headwinds overwhelmed pricing power. Operating margin (OPM) fell to 11.4% (FY26) from 14% (FY25), a 260 bp drop.
PAT slid 11% to ₹2,137 Cr. Tax swung sharply: FY26 tax rate was just 1% (₹19 Cr on ₹2,157 Cr PBT), a historical anomaly driven by prior-year reversals and tax adjustments. FY25 tax rate was 23%. Strip out tax volatility and underlying profit momentum was challenged.
Quarterly Trend (Q4 FY26):
Q4 FY26 revenue was ₹7,146 Cr (+16.9% YoY). But net profit in Q4 was ₹238 Cr, a 62.9% YoY collapse. Operating profit in Q4 was just ₹626 Cr (9% OPM) versus ₹837 Cr in Q4 FY25 (15% OPM). The quarter was compressed by peak cost escalation (West Asia conflict, bag/packing spikes, railway infrastructure delays) that management said would ease into FY27.
5. Market Expectations & Historical Multiples
This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.
| Metric | Current | Historical Avg (5yr) | Peer Median |
|---|---|---|---|
| P/E | 12.0 | ~20 | 28.68 |
| EV/EBITDA | 7.54 | ~10 | — |
| ROE | 10.9% | 12.6% | — |
| ROCE | 11.2% | 17% | 7.06% |
The market currently pays 12.0x earnings, against a five-year average of roughly 20x. Peer median (Ultratec, Grasim, Ambuja, Shree, JK, Dalmia) sits at 28.68x. ACC’s 12x is a discount to peers—partly because acquired-asset integration is seen as a drag, and partly because management credibility on cost guidance is being rebuilt after FY26 misses.
EV/EBITDA stands at 7.54x against a historical range of 8–12x. That suggests the market is pricing in margin recovery, not decline.
ROE at 10.9% is below the five-year average of 12.6% and well below the cost of equity. ROCE at 11.2% is also depressed, signaling that incremental capital deployed has not yet earned hurdle rates—a focus for FY27.
The market appears to be pricing in: (a) stabilization of acquired assets and margin recovery in FY27; (b) easing of input costs and freight; (c) partial pass-through of pricing as demand stabilizes. The discount to peers flags skepticism on the integration timeline.
6. What’s Cooking
Amalgamation with Ambuja (June 2026 status): Board approved the scheme in December 2025; BSE and NSE issued no-objection letters in June 2026. Ambuja will issue 328 shares per 100 ACC shares. Subject to NCLT and shareholder approval, expected completion within 12 months. Structure simplifies the holding but introduces execution risk mid-integration.
GST demand notices: Two orders totaling ~₹203.71 Cr in December 2025, and another ₹59.8 Cr in April 2026. Company disputes and will appeal. These are contingent liabilities, not cash outflows yet, but add legal drag.
Capex reset: FY26 capex was ~₹7,500 Cr; FY27 guidance is ₹6,000–6,500 Cr. Management explicitly acknowledged “a reset… moving away from the timeline” on long-term 155 MTPA capacity target. Projects now require 18% IRR hurdles and will be paced to execution capability.
Acquired-asset ramp-up: Penna, Sanghi, and Orient (acquired Sep 2025 at 72.66% for ₹5,910 Cr) are still in utilization catch-up. FY27 targets: Orient at full capacity, Sanghi 65–70%, Penna 55–60%. Legacy Ambuja+ACC: 75–80%. Group consolidated utilization expected ~70–75%, softer than pre-acquisition baseline.
Network redesign: Management flagged a multi-year shift to clinker-hub economics: Sanghi to become a clinker-only unit (clinker exported to coastal grinding units in Gujarat and elsewhere). Dahej Line 2 cited. This is a capex-light way to reduce logistics cost but requires 2–3 years to execute.
Renewable energy: Company has deployed 673 MW of wind/solar to date against a 1,000 MW target by end-FY26. Green power was 32% of Q4 fuel mix (up from 26% earlier), contributing to the ₹150–200/tonne cost-reduction targets in FY27.
7. Balance Sheet: Assets, Liabilities, a Lopsided Head-Scratch
| Item | FY26 | FY25 | FY24 |
|---|---|---|---|
| Total Assets | 27,525 | 25,413 | 23,386 |
| Net Worth | 20,551 | 18,555 | 16,330 |
| Borrowings | 429 | 430 | 355 |
| Other Liabilities | 6,546 | 6,428 | 6,701 |
| Total Liabilities | 27,525 | 25,413 | 23,386 |
Assets = Liabilities confirmed across all three years.
Three sarcastic bullets:
- ₹20,551 Cr net worth against ₹27,525 Cr total assets. The company is 75% equity-financed. In cement, where everyone operates at 60–80% utilization and input costs swing ±20% yearly, equity is cheap downside protection. But it also means management has room to destroy value before creditors twitch.
- CWIP (Capital Work in Progress) jumped ₹2,227 Cr, up from ₹2,061 Cr in FY25 and ₹986 Cr in FY24. These are projects mid-execution. The Orient acquisition added capex drag, and delays (contractor mismatches, engineering rework) mean more cash locked in half-finished assets. Until these commission, they are idle capital.
- Investments slot at ₹55 Cr (FY26) after ₹1,509 Cr in FY25. This whipsaw signals the company either sold investments (unlikely; more likely a reclassification tied to the Orient PPA allocation into goodwill/intangibles per management). Until the annual report clarifies, it’s a red herring, but watch it.
Net cash position: Borrowings ₹429 Cr (mostly term loans for capex). No material cash on the balance sheet disclosed separately in this extract. Management has stated “debt-free” position and CRISIL AAA rating, so liquidity is not a concern. The company can fund near-term capex and working capital easily.
Wisdom line: A balance sheet with nothing to hide—transparent, fortress-like, and utterly irrelevant to the challenge at hand. The problem is not balance sheet strength; it is capital productivity and operational execution.
8. Cash Flow: Sab Number Game Hai
| Year | Operating | Investing | Financing |
|---|---|---|---|
| FY24 | 2,995 | -1,205 | -443 |
| FY25 | 1,711 | -1,262 | -1,002 |
| FY26 | -1,364 | 1,273 | -422 |
FY24 CFO was ₹2,995 Cr—healthy cash generation. FY25 stepped down to ₹1,711 Cr as working capital consumed cash (receivables ticked up, inventory grew). FY26 went negative: -₹1,364 Cr.
Why? Working capital blew out: debtors jumped from 19 days (FY25) to 54 days (FY26), and inventory ballooned relative to sales. This is partly acquisition-related (new plants need ramp-up inventory and fresh-start payables), but partly a sign of demand softness (inventory not turning, sales on extended terms).
The -₹1,364 Cr CFO in FY26 was offset by +₹1,273 Cr from investing (asset sales, likely divestments tied to the network redesign or CWIP completions). Net cash flow was -₹513 Cr.
Wisdom line: Cash is the language earnings lie in, and FY26 is speaking softly: operating cash turned negative despite ₹2,137 Cr in earnings. That gap (₹2,137 Cr earnings, -₹1,364 Cr operating cash) is working capital deterioration—red flag if it persists into FY27.
9. Ratios: Sexy or Stressy?
| Ratio | FY26 | FY25 | Interpretation |
|---|---|---|---|
| ROE | 10.9% | 12.6% | Equity capital is earning sub-par returns. A 10% return is below most cost-of-capital estimates (12–14% range). |
| ROCE | 11.2% | 17% | Incremental capital invested in Penna, Sanghi, Orient has not yet earned hurdle rates. This is temporary while ramp-up happens, but it signals execution risk. |
| Debt/Equity | 0.02 | 0.02 | Nearly zero, a structural strength. But low leverage also means no financial engineering to smooth earnings. |
| OPM | 11.4% | 14% | Margin compression: 260 bp year-on-year. Input cost inflation and integration drag took out pricing power. |
| PAT Margin | 8.23% | 10.96% | Bottom-line margin fell harder than operating margin (due to lower other income and higher depreciation from new assets). |
Each ratio tells the same story: integration-related near-term pain, offset by a debt-free balance sheet that can absorb it. ROCE below cost of capital is the sore spot—until Penna/Sanghi/Orient hit 75%+ utilization and management delivers on cost guidance, returns will stay depressed.
10. P&L Breakdown: Show Me the Money
| Year | Revenue | EBITDA | PAT |
|---|---|---|---|
| FY24 | 19,959 | 3,062 | 2,336 |
| FY25 | 21,920 | 3,061 | 2,402 |
| FY26 | 25,962 | 2,958 | 2,137 |
Revenue has grown consistently: FY24 to FY25 (+10%), FY25 to FY26 (+18%). The acceleration in FY26 was driven by a full year of Penna (acquired mid-FY25, ~7.5 months in FY25 vs 12 in FY26) and the addition of Sanghi and Orient.
EBITDA has been stuck. FY24 ₹3,062 Cr, FY25 ₹3,061 Cr (flat), FY26 ₹2,958 Cr (down 3%). This is the critical tension: top-line growing double digits, but operating leverage absent. Margins compressed because acquired assets operate at lower utilization and higher per-unit costs than the legacy base.
PAT has also declined: from ₹2,402 Cr (FY25) to ₹2,137 Cr (FY26), a 11% drop. FY24 to FY25 saw a modest 3% rise. The trajectory is flattish-to-down despite volume growth—a negative working capital swing (working capital consumed ₹2.7 Bn in FY26 alone per CFO data) and added depreciation from ₹1,001 Cr (FY25) to ₹1,118 Cr (FY26).
Narrative of trajectory: Acquisition phase (scale up volume, absorb cost, accept margin compression) is underway. Management’s bet is FY27-FY28 cost reduction and utilization ramp will restore profitability and ROCE back toward the historical 17% range. This is a credibility test—FY26 missed internal cost targets, and ramp-up took longer than expected.
11. Peer Comparison
| Company | Revenue (Qtr) | PAT (Qtr) | P/E | ROCE |
|---|---|---|---|---|
| UltraTech Cem | 25,799 | 3,000 | 40.89 | 12.78% |
| Grasim | 51,101 | 3,802 | 42.42 | 8.07% |
| Ambuja | 10,915 | 1,857 | 21.32 | 5.61% |
| Shree Cement | 6,101 | 528 | 51.35 | 10.48% |
| JK Cements | 3,888 | 331 | 38.97 | 15.11% |
| Dalmia Bharat | 4,245 | 394 | 29.86 | 7.59% |
| ACC | 7,146 | 238 | 12.02 | 11.25% |
ACC’s quarterly revenue is ₹7,146 Cr, roughly one-quarter of UltraTech’s (₹25,799 Cr) but better than Ambuja standalone (₹10,915 Cr). However, ACC’s quarterly PAT is ₹238 Cr—the weakest in the peer set except Shree Cement’s ₹528 Cr. UltraTech earned ₹3,000 Cr in the same quarter.
On a normalized basis (stripping Q4 FY26 cost anomalies), ACC’s profit would be higher, but the gap to peers is still material. UltraTech and Grasim are larger and more diversified; Shree and JK are smaller but more profitable per unit. Ambuja is a peer within the same group, but stands apart due to Adani synergies and operational maturity.
ACC’s P/E of 12.02x is the lowest in this peer set (Ambuja at 21.3x is next). The market is pricing in either consolidation upside from the upcoming merger or continued near-term pain.
12. Shareholding & Promoters
| Holder | % |
|---|---|
| Promoters (Ambuja) | 56.7% |
| FIIs | 5.9% |
| DIIs | 21.6% |
| Public | 15.6% |
Ambuja Cements (50% + an additional 4.48% direct holding under Holcim nomenclature, plus 2.16% under Endeavour Trade, a related entity) holds 56.69% of ACC. The Adani group controls Ambuja via a September 2022 acquisition from Holcim.
FII stake has eroded: 10% in mid-2023, down to 5.9% now. This reflects either a rotation out (cement is cyclical, Adani group visibility has faced regulatory scrutiny) or profit-taking after weak FY26 results.
DII stake is steady at ~21.6%, anchored by LIC and large domestic asset managers (HDFC MF, SBI MF, Tata funds are the main holders per the shareholding breakout).
Public holdings at 15.6% suggest retail interest remains muted. The upcoming amalgamation will swap ACC shares for Ambuja at 328:100, which may reshuffle ownership but maintains the Adani control at the merged entity level.
Small promoter roast: The Ambuja-Adani group has consolidated cement assets (Ambuja, ACC, Sanghi, Penna, Orient, Dalmia minority), making it the second-largest player. But integration execution has been messier than the playbook promised. Repeated cost misses, capex timeline slippages, and working capital surprises suggest the “one cement platform” is still more aspiration than operating reality.
13. Corporate Governance: Angels or Devils?
Auditors: CRISIL rates ACC Crisil AAA/Stable for long-term debt, Crisil A1+ for short-term. No recent auditor changes flagged. Standard governance.
Board & Management: December 2025 saw Rakesh Tiwary step down as CFO; Rohit Soni appointed. November 2025 saw Navin Malhotra resign as Chief Sales & Marketing Officer. These mid-level departures are noise, but the CFO change mid-quarter suggests some internal friction around the financial guidance or reporting on the integration.
Pledges: None disclosed. Promoter stake is clean.
Related-party transactions: MSA with Ambuja (6.6 Mt of clinker/cement sold in FY24) is material and approved. October 2025 postal ballot approved up to ₹2,800 Cr in material RPTs with Penna. These are normal for a group company post-acquisition but warrant watching to ensure transfer pricing is arm’s-length.
Tax demands: Two GST orders totaling ~₹203.71 Cr (December 2025) and ₹59.8 Cr (April 2026). Company disputes and will appeal. Income tax demands also pending (₹14.22 Cr for AY2015-16, ₹8.85 Cr for AY2018-19, company to appeal). These are standard audit niggles in a large cement company but do add execution drag if drawn-out litigation consumes management bandwidth.
Scheme of Amalgamation: Approved by board December 2025; BSE/NSE no-objection letters June 2026. Subject to NCLT and shareholder vote, but structural change is coming. Neutral from a governance standpoint (simplifies the holding) but a near-term distraction.
Red flags as facts: CFO swap and sales-head resignation mid-integration point to internal debates over guidance credibility. Pending GST/tax cases are liabilities but not solvency threats. The upcoming amalgamation is transformational but expected.
14. Industry Roast & Macro Context
Cement is a commodities grind: oversupply cycles, price wars, margin compression, repeat.
Indian cement capacity is clustered in the North (NCR, Punjab, UP) and South (Andhra, Tamil Nadu), with Western plants (Gujarat) supplying metros and coastal projects. Logistics (trucking, rail, coastal shipping) eats 30–40% of per-unit costs—and freight pricing is set by infrastructure, fuel, and demand peaks.
Pricing wars: When utilization drops below 70%, players slash prices. FY26 did not see a hard crunch (demand was still decent at +9% for the industry), but ACC faced pressure to price selectively (realization was modest, premiumization at 36% trade means discounting on base products to keep volume). Peers like UltraTech hold pricing power due to scale and brand; smaller players (Dalmia, Sanghi pre-acquisition) are more exposed.
Distribution & logistics: ACC’s 13,000-channel-partner, 39,600-retailer network is wide but uneven. Rural and Tier-2 reach is essential but expensive (sub-scale transport, payment risk, inventory holdups). The MSA with Ambuja offloads some distribution pressure but creates dependency on Ambuja’s network maturity. The network redesign (moving grinding closer to demand, Sanghi as clinker hub) is operationally sound but takes 2–3 years.
Input volatility: Fuel (coal, alternative fuels, LNG) has gyrated; power costs are sticky (captive plants help but capex-heavy); raw material (limestone, fly ash) availability varies by region. FY26 saw coal and fuel costs ease compared to global highs, but West Asia logistics snarls spiked packing costs mid-quarter. This volatility will persist.
Regulation & climate: Cement is energy-intensive and carbon-laden. India’s push for renewable power in cement plants (target 30% green energy share) is positive for companies with capital access (ACC, Ambuja, UltraTech) and negative for smaller players (Dalmia, Sanghi pre-acquisition). ACC’s 1,000 MW renewable target by FY28 aligns with this macro but is a capex drag in the near term.
Demand macro: Construction activity (residential, infrastructure, industrial) drives volume. RBI rate hikes have cooled residential demand (affordability), but government capex (roads, railways, metros) is steady. Management guided FY27 volume growth at ~5–5.5% for the industry, below prior trends, due to inflation headwinds and weak monsoon risk (agrarian demand is delayed). ACC’s volume growth guidance (internal, ~80 Mt or ~8% from FY26’s ~74 Mt) exceeds the industry, betting on premiumization and ramp-up of acquired capacity.
15. EduInvesting Verdict
| Strengths | Second-largest cement group (Ambuja + ACC, 107 MTPA); debt-free balance sheet; CRISIL AAA rating; renewable energy (32% of mix, 1,000 MW target by FY28); distribution scale (13,000+ partners) |
| Weaknesses | Integration execution lagging (Penna/Sanghi/Orient utilization below 70%); ROCE below cost of capital (11.2%); working capital deterioration (debtor days 54 vs 15 target); capex guidance reset signals credibility gap; OPM compressed 260 bp YoY |
| Opportunities | Premiumization (36% premium cement sales, ₹20–55/bag uplift); network redesign (clinker-hub model, logistics cost savings); Green power deployment; MSA with Ambuja (volume security); Consolidation upside from merger into Ambuja |
| Threats | Commodity pricing (industry utilization 70–75%, margin compression risk); freight and fuel volatility; GST/tax litigations (₹263+ Cr pending); construction demand softness (5–5.5% FY27 guidance); capex execution risk (timeline slippages, cost overruns) |
A decade of solid fundamentals (debt-free, steady volume growth, scale) has collided with a three-year M&A sprint (Penna, Sanghi, Orient) that is executing worse than the playbook promised. Costs peaked in Q4, management says, but “peak” has credibility gaps—the company missed internal targets in FY24 and FY25, and now FY26.
The balance sheet is impeccable; the operations are in transition. Ambuja (parent) is larger and older, with a track record of delivery. ACC’s history is similarly sound until the integration cycle. The question is how quickly Penna/Sanghi/Orient reach 75%+ utilization and legacy cost-run targets (₹4,000–4,100/tonne) are restored. If FY27 cost guidance holds (₹4,250/tonne average, down ₹250 from peak), ROCE and margins will inflect upward. If execution slips again, the multiple will compress further.
The upcoming merger into Ambuja simplifies legal structure but adds near-term governance complexity. The company is credible on long-term strategic vision (clinker hubs, renewables, group synergies) and balance sheet management, but near-term execution credibility is on trial. A company with everything to prove and time to prove it.